141 related articles for article (PubMed ID: 30136104)
1. Transforming growth factor-β1 in children with diabetic nephropathy.
Sawires H; Botrous O; Aboulmagd A; Madani N; Abdelhaleem O
Pediatr Nephrol; 2019 Jan; 34(1):81-85. PubMed ID: 30136104
[TBL] [Abstract][Full Text] [Related]
2. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
[TBL] [Abstract][Full Text] [Related]
3. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Shaker OG; Sadik NA
Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 in diabetic nephropathy.
Metwally SS; Mosaad YM; Nassr AA; Zaki OM
Egypt J Immunol; 2005; 12(1):103-12. PubMed ID: 16734145
[TBL] [Abstract][Full Text] [Related]
6. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
7. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
[TBL] [Abstract][Full Text] [Related]
8. Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus.
Metwalley KA; Farghaly HS; Gabri MF; Abdel-Aziz SM; Ismail AM; Raafat DM; Elnakeeb IF
J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):293-299. PubMed ID: 33565751
[TBL] [Abstract][Full Text] [Related]
9. [Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].
Paczek L; Kropiewnicka HE; Senatorski G; Bartłomiejczyk I
Pol Arch Med Wewn; 2002 Aug; 108(2):745-52. PubMed ID: 12476894
[TBL] [Abstract][Full Text] [Related]
10. Serum cathelicidin as a marker for diabetic nephropathy in patients with type 1 diabetes.
El-Ashmawy HM; Ahmed AM
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3057. PubMed ID: 30091508
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive method of differentiating diabetic nephropathy and nondiabetic renal disease using serum bone morphogenetic protein-7 and transforming growth factor-beta 1 levels in patients with type-2 diabetes mellitus.
John P; Yadla M
Saudi J Kidney Dis Transpl; 2019; 30(6):1300-1309. PubMed ID: 31929277
[TBL] [Abstract][Full Text] [Related]
12. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
13. Significant correlation between association of polymorphism in codon 10 of transforming growth factor-beta1 T (29) C with type 1 diabetes and patients with nephropathy disorder.
Jahromi MM; Millward BA; Demaine AG
J Interferon Cytokine Res; 2010 Feb; 30(2):59-66. PubMed ID: 20039825
[TBL] [Abstract][Full Text] [Related]
14. The effect of ramipril therapy on cytokines and parameters of incipient diabetic nephropathy in patients with type 1 diabetes mellitus.
Janickova Zdarska D; Zavadova E; Kvapil M
J Int Med Res; 2007; 35(3):374-83. PubMed ID: 17593866
[TBL] [Abstract][Full Text] [Related]
15. Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.
Mou X; Zhou DY; Zhou DY; Ma JR; Liu YH; Chen HP; Hu YB; Shou CM; Chen JW; Liu WH; Ma GL
PLoS One; 2016; 11(2):e0149513. PubMed ID: 26901047
[TBL] [Abstract][Full Text] [Related]
16. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
[TBL] [Abstract][Full Text] [Related]
17. Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling.
Xin C; Xia Z; Jiang C; Lin M; Li G
Drug Des Devel Ther; 2015; 9():6269-74. PubMed ID: 26664048
[TBL] [Abstract][Full Text] [Related]
18. [Infect of pingshen decoction on serum HGF, Cys C and TGF-beta1 diabetic nephropathy in early stage].
Bao HL; Ye SH; Lou SX; Lu XW; Zhou XF
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):1128-31. PubMed ID: 24956865
[TBL] [Abstract][Full Text] [Related]
19. Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus.
Yürük Yıldırım Z; Yılmaz A; Pehlivanoğlu C; Gedikbaşı A; Yıldız M; Dirican A; Bundak R; Darendeliler F; Emre S; Nayır A
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):157-163. PubMed ID: 30396876
[TBL] [Abstract][Full Text] [Related]
20. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
Ibrahim S; Rashed L
Saudi Med J; 2007 Apr; 28(4):519-23. PubMed ID: 17457470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
